Jennifer L Lund

Summary

Affiliation: Aarhus University Hospital
Country: Denmark

Publications

  1. pmc Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients
    Jennifer L Lund
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Cancer 119:2038-47. 2013
  2. pmc Identifying specific chemotherapeutic agents in Medicare data: a validation study
    Jennifer L Lund
    Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Med Care 51:e27-34. 2013
  3. pmc Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data
    Jennifer L Lund
    Department of Epidemiology, University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina, USA
    Inflamm Bowel Dis 17:787-94. 2011
  4. doi request reprint Decrease in Incidence of Colorectal Cancer Among Individuals 50 Years or Older After Recommendations for Population-based Screening
    Caitlin C Murphy
    Division of Epidemiology, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Electronic address
    Clin Gastroenterol Hepatol . 2016
  5. pmc Patterns of Colorectal Cancer Care in the United States: 1990-2010
    Caitlin C Murphy
    Affiliations Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC CCM, JLL Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD LCH, AMG Department of Epidemiology, University of Iowa, Iowa City, IA CFL
    J Natl Cancer Inst 107:. 2015
  6. pmc Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy
    Jennifer L Lund
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA Electronic address
    J Geriatr Oncol 7:176-86. 2016
  7. pmc Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
    Hanna K Sanoff
    University of North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA Division of Hematology Oncology, University of North Carolina, Chapel Hill, North Carolina, USA
    Oncologist 21:1113-20. 2016
  8. pmc Predictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data
    Jessica C Young
    Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Pharmacoepidemiol Drug Saf 25:836-43. 2016
  9. pmc The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application
    Jennifer L Lund
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC
    Curr Epidemiol Rep 2:221-228. 2015
  10. pmc Comparison of SEER Treatment Data With Medicare Claims
    Anne Michelle Noone
    Division of Cancer Control and Population Sciences, Surveillance Research Program, National Cancer Institute, Bethesda, MD Department of Epidemiology, Gillings School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC Information Management Services Inc, Calverton, MD Los Angeles Cancer Surveillance Program, Keck School of Medicine, University of Southern California, Los Angeles, CA Division of Cancer Control and Population Sciences, Applied Research Program, National Cancer Institute, Bethesda, MD
    Med Care 54:e55-64. 2016

Collaborators

Detail Information

Publications13

  1. pmc Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients
    Jennifer L Lund
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Cancer 119:2038-47. 2013
    ..This study sought to identify patient/tumor, physician, hospital, and geographic factors associated with oxaliplatin use among older patients...
  2. pmc Identifying specific chemotherapeutic agents in Medicare data: a validation study
    Jennifer L Lund
    Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Med Care 51:e27-34. 2013
    ..Misclassification of chemotherapy could bias estimates of frequency and association, warranting an updated assessment...
  3. pmc Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data
    Jennifer L Lund
    Department of Epidemiology, University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina, USA
    Inflamm Bowel Dis 17:787-94. 2011
    ..We examined the association between thiazolidinedione use and ulcerative colitis (UC)-related flares...
  4. doi request reprint Decrease in Incidence of Colorectal Cancer Among Individuals 50 Years or Older After Recommendations for Population-based Screening
    Caitlin C Murphy
    Division of Epidemiology, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Electronic address
    Clin Gastroenterol Hepatol . 2016
    ..At the same time, there has been controversy over whether reductions in CRC incidence can be attributed to screening. We examined age-related and race-related differences in CRC incidence during a 40-year time period...
  5. pmc Patterns of Colorectal Cancer Care in the United States: 1990-2010
    Caitlin C Murphy
    Affiliations Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC CCM, JLL Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD LCH, AMG Department of Epidemiology, University of Iowa, Iowa City, IA CFL
    J Natl Cancer Inst 107:. 2015
    ..Colorectal cancer (CRC) mortality has declined in the United States, in part because of advances in treatment. Few studies have evaluated the adoption of therapies and temporal changes in patterns of care...
  6. pmc Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy
    Jennifer L Lund
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA Electronic address
    J Geriatr Oncol 7:176-86. 2016
    ..The objective of the study was to evaluate the comparative effectiveness of postoperative chemotherapy following CRT or radiation therapy (RT) with specific attention to the impact of age on postoperative chemotherapy effectiveness...
  7. pmc Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
    Hanna K Sanoff
    University of North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA Division of Hematology Oncology, University of North Carolina, Chapel Hill, North Carolina, USA
    Oncologist 21:1113-20. 2016
    ..Because of narrow trial eligibility, results may not be generalizable to a broader HCC population. We sought to evaluate the effectiveness of initial sorafenib versus no treatment among Medicare beneficiaries with advanced HCC...
  8. pmc Predictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data
    Jessica C Young
    Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Pharmacoepidemiol Drug Saf 25:836-43. 2016
    ..Few studies have evaluated the degree to which prescription drug initiators are correctly identified using claims data. We examine the prevalence and predictors of recent statin possession in statin initiators identified using claims data...
  9. pmc The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application
    Jennifer L Lund
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC
    Curr Epidemiol Rep 2:221-228. 2015
    ..Finally, we provide an empirical example in which the active comparator, new user study design addresses biases that have previously impeded pharmacoepidemiologic studies...
  10. pmc Comparison of SEER Treatment Data With Medicare Claims
    Anne Michelle Noone
    Division of Cancer Control and Population Sciences, Surveillance Research Program, National Cancer Institute, Bethesda, MD Department of Epidemiology, Gillings School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC Information Management Services Inc, Calverton, MD Los Angeles Cancer Surveillance Program, Keck School of Medicine, University of Southern California, Los Angeles, CA Division of Cancer Control and Population Sciences, Applied Research Program, National Cancer Institute, Bethesda, MD
    Med Care 54:e55-64. 2016
    ..Activities are ongoing to investigate the opportunity to supplement SEER treatment data with other data sources...
  11. pmc Use of qualitative methods in published health services and management research: a 10-year review
    Bryan J Weiner
    Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7411, USA
    Med Care Res Rev 68:3-33. 2011
    ..Half of qualitative research articles provided little or no detail about key aspects the study's methods. Implications are discussed and recommendations are offered for promoting the publication of qualitative research...
  12. pmc Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease
    Jennifer L Lund
    Department of Epidemiology, University of North Carolina, Chapel Hill, 27599 7435, USA
    Cancer Invest 28:758-64. 2010
    ..Our findings support the usefulness of site and cancer cause-specific causes of death reported on the death certificate for distant stage patients with a single cancer...